Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say

Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights Nov 1(Reuters) - Moderna (MRNA.O) should hit the lower end of its sales target for this year as it only needs to…#moderna #oppenheimerco #hartajsingh #jefferies #michaelyee #yee #pfizer #rsv #gsk

Source: Reuters: Health - November 1, 2023 Category: Consumer Health News Source Type: news